BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22987068)

  • 1. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
    Taniguchi Y; Sasaki S
    Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient DNA strand displacement by a W-shaped nucleoside analogue (WNA-βT) containing an ortho-methyl-substituted phenyl ring.
    Aoki E; Taniguchi Y; Wada Y; Sasaki S
    Chembiochem; 2012 May; 13(8):1152-60. PubMed ID: 22549913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the aromatic ring of the WNA analogues for expansion of the triplex recognition codes.
    Taniguchi Y; Nakamura A; Aoki E; Sasaki S
    Nucleic Acids Symp Ser (Oxf); 2005; (49):173-4. PubMed ID: 17150689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of a stable triplex incorporating a CG interrupting site by a new WNA derivative containing 3-aminopyrazole as a nucleobase.
    Uchida Y; Taniguchi Y; Aoki E; Togo M; Sasaki S
    Nucleic Acids Symp Ser (Oxf); 2008; (52):137-8. PubMed ID: 18776291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of halogenated WNA derivatives on sequence dependency for expansion of recognition sequences in non-natural-type triplexes.
    Taniguchi Y; Nakamura A; Senko Y; Nagatsugi F; Sasaki S
    J Org Chem; 2006 Mar; 71(5):2115-22. PubMed ID: 16497000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the modified aromatic ring of WNA on stability of triplex DNA.
    Aoki E; Taniguchi Y; Togo M; Sasaki S
    Nucleic Acids Symp Ser (Oxf); 2006; (50):185-6. PubMed ID: 17150879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of CG interrupting site by W-shaped nucleoside analogs (WNA) having the pyrazole ring in an anti-parallel triplex DNA.
    Taniguchi Y; Uchida Y; Takaki T; Aoki E; Sasaki S
    Bioorg Med Chem; 2009 Oct; 17(19):6803-10. PubMed ID: 19736014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective formation of stable triplexes including a TA or a CG interrupting site with new bicyclic nucleoside analogues (WNA).
    Sasaki S; Taniguchi Y; Takahashi R; Senko Y; Kodama K; Nagatsugi F; Maeda M
    J Am Chem Soc; 2004 Jan; 126(2):516-28. PubMed ID: 14719949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective strand invasion ODN incorporating a new bicyclic nucleoside analogue (WNA).
    Aoki E; Taniguchi Y; Sasaki S
    Nucleic Acids Symp Ser (Oxf); 2007; (51):255-6. PubMed ID: 18029683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-substituted pyrimidine nucleoside bases of WNA on stability of triplex DNA.
    Taniguchi Y; Nakamura A; Senko Y; Sasaki S
    Nucleic Acids Symp Ser (Oxf); 2004; (48):69-70. PubMed ID: 17150482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
    Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
    Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective formation of non-natural type triplexes containing TA interrupting sites with the TFO incorporating W-shape nucleic acid (WNA) analogs.
    Taniguchi Y; Takahashi R; Kodama K; Senko Y; Maeda M; Sasaki S
    Nucleic Acids Res Suppl; 2002; (2):35-6. PubMed ID: 12903092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure.
    Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T
    Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells.
    Shen C; Buck A; Polat B; Schmid-Kotsas A; Matuschek C; Gross HJ; Bachem M; Reske SN
    Cancer Gene Ther; 2003 May; 10(5):403-10. PubMed ID: 12719710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transcription and antiproliferative effects in a cancer cell line using antigene oligonucleotides containing artificial nucleoside analogues.
    Wang L; Notomi R; Sasaki S; Taniguchi Y
    RSC Med Chem; 2023 Aug; 14(8):1482-1491. PubMed ID: 37593572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.
    McGuffie EM; Pacheco D; Carbone GM; Catapano CV
    Cancer Res; 2000 Jul; 60(14):3790-9. PubMed ID: 10919652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
    Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
    Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
    Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
    Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of novel nucleoside analogs (WNA) for specific formation of non-natural type triplexes containing a TA or CG interrupting site.
    Taniguchi Y; Senko Y; Kodama K; Nakamura A; Sasaki S
    Nucleic Acids Res Suppl; 2003; (3):113-4. PubMed ID: 14510406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.